MAPS EXPERIENTIAL TRAINING PARTNERSHIP
PSYCHEDELIC EXPERIENTIAL OPPORTUNITIES FOR MDMA-ASSISTED THERAPY
Numinus has submitted a Clinical Trial Application (CTA) to Health Canada to enable MDMA-Assisted Therapy Experiential Opportunities for practitioners as part of an investigational Phase 1 clinical trial.If approved, Numinus intends to make the Experiential Opportunity available to practitioners as part of its psychedelic-assisted therapy education and training program.
If the CTA is approved, MAPS will provide Numinus with permission to use its protocol as part of this Experiential Opportunity, the first such permission granted by MAPS.
HOW YOU CAN GET INVOLVED
Practitioners who complete our MDMA-Assisted Therapy education program, or have already completed previous MDMA-Assisted Therapy training and are qualified to enroll in our Practical Applications course, would be able to apply to participate in the experiential clinical trial - enabling them to observe, deliver, and receive the therapeutic protocol as part of their training experience. Sign up for our mailing list below to be notified when applications open.
BE THE FIRST TO KNOW
Stay up to date on MDMA-Assisted Therapy opportunities and our partnership with MAPS.
